TETRAPHASE PHARMACEUTICALS I - COM (TTPH)

CUSIP: 88165N105

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
18,011,916
Share change
-2,310,977
Total reported value
$72,574,705
Put/Call ratio
111%
Price per share
$4.03
Number of holders
88
Value change
-$8,859,291
Number of buys
44
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 88165N105?
CUSIP 88165N105 identifies TTPH - TETRAPHASE PHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q4 2016

As of 31 Dec 2016, TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,011,916 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, CANADA PENSION PLAN INVESTMENT BOARD, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, STATE STREET CORP, Rock Springs Capital Management LP, and EVENTIDE ASSET MANAGEMENT, LLC. This page lists 88 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.